• Biohaven promoted David Pirman to executive vice president, head of discovery to run internal drug discovery and oversee research programs.
• Bruce Car to step down as chief scientific officer on July 13, 2026; shifts to part-time chief innovation officer focused on external collaborations.
• Car to lead multiple assets under the company’s collaboration with Bexorg; remains an executive officer.
• General Counsel Warren Volles designated an executive officer; continues to lead the legal function.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohaven Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607091700PR_NEWS_USPR_____NE01356) on July 09, 2026, and is solely responsible for the information contained therein.